More News! 10 Dec 2024 Biotech in 2024: A retrospective 2024 is coming to a close and it is time to look at how biotech performed this year. Was it a triumph or a year of cautious optimism? December 10, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 6 Dec 2024Cracking the code of biotech valuations Our guest on the podcast this week to discuss the biotech scene in Eastern Europe, and look at some of the challenges facing biotech companies is Adam Marťák, CEO of ambiom. December 6, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 5 Dec 2024 The biggest private biotech investments in November 2024 The companies Metsera, Alentis Therapeutics, and Adcendo bagged the biggest private biotech investments in November 2024. December 5, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 18 Nov 2024 What is Abcam’s founder, Jonathan Milner, up to? Since Abcam was acquired in December 2023, its founder, Jonathan Milner has been very active. Delve into his investment strategy. November 18, 2024 - 17 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Expert Advice 15 Nov 2024 How biotech startups become unicorns Delve into what differentiates a successful biotech startup from a unicorn reaching a $1 billion valuation. November 15, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 15 Nov 2024Beyond profits: The Bill & Melinda Gates MRI’s mission to combat neglected diseases This week, our guest is Dr Claire Wagner, head of corporate strategy and market access at the Bill & Melinda Gates Medical Research Institute (Gates MRI). November 15, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 11 Nov 2024 Gene editing sector investment struggles: What’s driving the slowdown? Find out what is driving the slowdown in gene therapy investment, as the sector continues to struggle with widespread layoffs. November 11, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 7 Nov 2024 The biggest private biotech investments in October 2024 The companies Treeline Biosciences, Kailera Therapeutics, and Seaport Therapeutics bagged the biggest private biotech investments in October 2024. November 7, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 5 Nov 2024 From consumer health to pure biopharma: Inside Sanofi’s strategic shift Delve into Sanofi’s “play to win” strategy as investments are ramping up after their consumer health division’s divestment. November 5, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 4 Oct 2024 The biggest private biotech investments in September 2024 The companies Candid Therapeutics, ArsenalBio, and eGenesis bagged the biggest private biotech investments in September 2024. October 4, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 12 Sep 2024 Biotech R&D crunch: The impact of the Inflation Reduction Act and economic challenges Delve into the consequences of the Inflation Reduction Act and the broader economic conditions on biotech R&D. September 12, 2024 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 5 Sep 2024 The biggest private biotech investments in August 2024 The companies Borealis Biosciences, Outpace Bio, and Halda Therapeutics bagged the biggest private biotech investments in August 2024. September 5, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email